Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysisCancer Treat. Rev 2022 Jul 26;110(2022)102441, G Fallara, D Robesti, L Nocera, D Raggi, L Marandino, F Belladelli, F Montorsi, B Malavaud, G Ploussard, A Necchi, A Martini
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.